ARRIVENT BIOPHARMA INC (AVBP) Stock Cash Flow
NASDAQ:AVBP - Nasdaq - US04272N1028 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -81.05M | -69.33M | -36.91M | -51.61M | |||
| Change In Working Capital | 9.50M | 12.60M | -7.15M | -3.94M | |||
| Other non cash items | 2.58M | 895.00K | 424.00K | 42.96M | |||
| OPERATING CASH FLOW | -68.97M | -55.84M | -43.63M | -12.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Other Investing Activity | N/A | 0.00 | 0.00 | -40.00M | |||
| INVESTING CASH FLOW | N/A | 0.00 | 0.00 | -40.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 186.81M | 45.27M | 169.72M | 89.87M | |||
| Other Financing Activity | N/A | -2.41M | N/A | N/A | |||
| FINANCING CASH FLOW | 185.47M | 42.86M | 169.72M | 89.87M | |||
| CHANGE IN CASH | 141.50M | -12.98M | 126.09M | 37.28M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -68.97M | -55.84M | -43.63M | -12.59M | |||
| FREE CASH FLOW | -68.97M | -55.84M | -43.63M | -12.59M | |||
All data in USD